Scientists at Edinburgh's Roslin Institute have made a groundbreaking discovery, successfully creating pigs that are resistant to classical swine fever (CSF), a highly contagious and often fatal disease. The breakthrough comes after years of research into gene editing technologies, which aim to bolster the resilience of livestock against devastating diseases.
According to experts, CSF has been a major threat to pig farming worldwide since its eradication in the UK in 1966. Despite efforts by countries such as China, Russia, and Brazil, where the disease is endemic, outbreaks continue to occur due to costly and labor-intensive vaccination programs and international trade restrictions.
In a remarkable study published in Trends in Biotechnology, researchers used gene editing technology to introduce a specific edit to the DNA of pigs, targeting a protein called DNAJC14. This protein plays a critical role in the replication of pestiviruses, which include CSF. The results showed that four pigs with the edited gene were completely healthy and showed no signs of infection when exposed to CSF, whereas their control counterparts developed symptoms of the disease and had high levels of the virus in their blood.
The study's findings have significant implications for pig farming worldwide, as they demonstrate a potential solution to this devastating disease. Experts hail the breakthrough as a major step forward in using genomics-enabled innovation to build resilience to disease in livestock populations.
"This virus has a severe effect on animal welfare and productivity," said Dr Christine Tait-Burkard, a group leader at the Roslin Institute. "We're hopeful that our discovery can help reduce losses for farmers and improve the overall health of pigs worldwide."
While the study focused on CSF, researchers are now exploring whether the same gene edit could confer resistance to other diseases affecting cattle and sheep in the UK.
As countries continue to relax rules around gene editing in agriculture, this breakthrough serves as a reminder of the potential benefits of such technology. The UK's Precision Breeding Act has paved the way for gene-edited crops, while countries such as the US, Japan, and Brazil have already approved gene-edited livestock.
The development of disease-resistant pigs has sparked debate about the ethics of genetic modification in agriculture. "In my mind, there is a moral imperative that if we can make animals that are disease resistant, then we probably should do," said Dr Simon Lillico, a research scientist at the Roslin Institute.
Dr Emily Clark of EMBL's European Bioinformatics Institute added: "Decades of genomic research have made it possible to pinpoint and precisely edit the genes involved in disease resistance. Research like this is helping to create healthier animals, reduce losses for farmers, and marks a major step forward in using genomics-enabled innovation to build resilience to disease in livestock populations."
According to experts, CSF has been a major threat to pig farming worldwide since its eradication in the UK in 1966. Despite efforts by countries such as China, Russia, and Brazil, where the disease is endemic, outbreaks continue to occur due to costly and labor-intensive vaccination programs and international trade restrictions.
In a remarkable study published in Trends in Biotechnology, researchers used gene editing technology to introduce a specific edit to the DNA of pigs, targeting a protein called DNAJC14. This protein plays a critical role in the replication of pestiviruses, which include CSF. The results showed that four pigs with the edited gene were completely healthy and showed no signs of infection when exposed to CSF, whereas their control counterparts developed symptoms of the disease and had high levels of the virus in their blood.
The study's findings have significant implications for pig farming worldwide, as they demonstrate a potential solution to this devastating disease. Experts hail the breakthrough as a major step forward in using genomics-enabled innovation to build resilience to disease in livestock populations.
"This virus has a severe effect on animal welfare and productivity," said Dr Christine Tait-Burkard, a group leader at the Roslin Institute. "We're hopeful that our discovery can help reduce losses for farmers and improve the overall health of pigs worldwide."
While the study focused on CSF, researchers are now exploring whether the same gene edit could confer resistance to other diseases affecting cattle and sheep in the UK.
As countries continue to relax rules around gene editing in agriculture, this breakthrough serves as a reminder of the potential benefits of such technology. The UK's Precision Breeding Act has paved the way for gene-edited crops, while countries such as the US, Japan, and Brazil have already approved gene-edited livestock.
The development of disease-resistant pigs has sparked debate about the ethics of genetic modification in agriculture. "In my mind, there is a moral imperative that if we can make animals that are disease resistant, then we probably should do," said Dr Simon Lillico, a research scientist at the Roslin Institute.
Dr Emily Clark of EMBL's European Bioinformatics Institute added: "Decades of genomic research have made it possible to pinpoint and precisely edit the genes involved in disease resistance. Research like this is helping to create healthier animals, reduce losses for farmers, and marks a major step forward in using genomics-enabled innovation to build resilience to disease in livestock populations."